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Hypertension is one of the most frequent pathologies in the industrialized world.
Although recognized to be dependent on a combination of genetic and
environmental factors, its molecular basis remains elusive. Increased activity of the
monomeric G protein RhoA in arteries is a common feature of hypertension.
However, how RhoA is activated and whether it has a causative role in hypertension
remains unclear. Here we provide evidence that Arhgef1 is the RhoA guanine
exchange factor specifically responsible for angiotensin II-induced activation of
RhoA signaling in arterial smooth muscle cells. We found that angiotensin II
activates Arhgef1 through a previously undescribed mechanism in which Jak2
phosphorylates Tyr738 of Arhgef1. Arhgef1 inactivation in smooth muscle induced
resistance to angiotensin II-dependent hypertension in mice, but did not affect
normal blood pressure regulation. Our results show that control of RhoA signaling
through Arhgef1 is central to the development of angiotensin II-dependent






































Publié sur Okina (http://okina.univ-angers.fr)
